Piramal Pharma Ltd. logo

Piramal Pharma Ltd. (PPLPHARMA)

Market Closed
8 Dec, 22:00
MSE MSE
174. 65
-5.3
-2.95%
- Market Cap
- P/E Ratio
0% Div Yield
191,019 Volume
0 Eps
179.95
Previous Close
Day Range
173.4 180.15
Year Range
173.4 273.2
Want to track PPLPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 50 days

Summary

PPLPHARMA closed today lower at ₹174.65, a decrease of 2.95% from yesterday's close, completing a monthly decrease of -11.7% or ₹23.15. Over the past 12 months, PPLPHARMA stock lost -34.28%.
PPLPHARMA pays dividends to its shareholders, with the most recent payment made on Aug 29, 2025. The next estimated payment will be in 3 months ago on Aug 29, 2025 for a total of ₹0.14.
The last earnings report, released on Nov 05, 2025, missed the consensus estimates by -0.46%. On average, the company has fell short of earnings expectations by -0.05%, based on the last three reports. The next scheduled earnings report is due on Jan 27, 2026.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XNSE (INR).

PPLPHARMA Chart

Piramal Pharma Ltd. (PPLPHARMA) FAQ

What is the stock price today?

The current price is ₹174.65.

On which exchange is it traded?

Piramal Pharma Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is PPLPHARMA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.22.

When is the next earnings date?

The next earnings report will release on Jan 27, 2026.

Has Piramal Pharma Ltd. ever had a stock split?

No, there has never been a stock split.

Piramal Pharma Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Nandini Ajay Piramal CEO
MSE Exchange
INE0DK501011 ISIN
IN Country
6,295 Employees
16 Jul 2025 Last Dividend
- Last Split
- IPO Date

Overview

Piramal Pharma Limited, established in 2020, marks its presence in the pharmaceutical industry by offering a wide range of products and comprehensive services. With its headquarters in Mumbai, India, the company quickly asserted itself as a significant player in the pharma sector. Operating as a subsidiary of Piramal Enterprises Limited, Piramal Pharma Limited delivers excellence and innovation, focusing on meeting the diverse needs of its customers globally. Its foundation is built on a strong ethos of quality, integrity, and groundbreaking healthcare solutions, aiming to contribute significantly to the well-being of individuals around the world.

Products and Services

  • Pharma Products

    The core offerings of Piramal Pharma Limited include a comprehensive portfolio of pharmaceutical products. These products encompass a variety of therapeutic areas, aiming to address the pressing health concerns of today. With a commitment to quality and efficacy, the company ensures that its products meet the highest standards, catering to the global market with unparalleled excellence.

  • Injection Services

    Recognizing the critical role of injections in the administration of treatments, Piramal Pharma Limited provides specialized injection services. This service comprises the development and manufacturing of injectable formulations, ensuring safe, effective, and high-quality delivery mechanisms for medications. Catering to diverse medical fields, these services underscore the company's commitment to innovative solutions in pharma logistics and administration.

  • HPAPI

    High Potency Active Pharmaceutical Ingredients (HPAPIs) represent another cornerstone of Piramal Pharma Limited's offerings. The company's capabilities in handling HPAPIs demonstrate its expertise in the pharmaceutical manufacturing domain, particularly in producing potent substances that require additional care in production and handling. With a focus on safety and quality, Piramal Pharma Limited supports the development of cutting-edge treatments for severe diseases, making significant contributions to the advancement of medical science.

Contact Information

Address: Piramal Ananta, Mumbai, India, 400 070
Phone: 91 22 3802 3000